10050-TB-1 ADDITIONAL RAS/MAPK PATHWAY ACTIVATION ALLOWS CELLS TO DIFFERENTIATE DURING TUMORIGENESIS.

Shunichiro Miki, Tomoyuki Koga, Frank Furnari · 2023

Read 10050-TB-1 ADDITIONAL RAS/MAPK PATHWAY ACTIVATION ALLOWS CELLS TO DIFFERENTIATE DURING TUMORIGENESIS. by Shunichiro Miki, Tomoyuki Koga, Frank Furnari (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10710633.txt.

Description

Shunichiro Miki, Tomoyuki Koga, and Frank Furnari report a laboratory study of glioblastoma, published in two thousand twenty-three. The work asks how activation of the RAS/MAPK signaling pathway changes tumor formation in cells at different stages of development.

The team grew human stem cells carrying several glioblastoma-linked mutations and turned them into neural stem cells and astrocytes. Adding the EGFRvIII gene sped tumor growth in stem cells and was required for tumors in astrocytes. Tumors from both cell types looked alike under RNA sequencing. The authors conclude that pathway activation lets even differentiated cells transform and form tumors.

Catalog record

CREATORShunichiro Miki, Tomoyuki Koga, Frank Furnari
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10710633

Browse the full library · About the Tower of Babel